Quarterly Result14 Aug 2026, 07:04 pm
Lasa Supergenerics declares Q1 FY27 unaudited results
AI Summary
Lasa Supergenerics Limited has submitted its integrated filing for the quarter ended June 30, 2026. The Board of Directors approved the unaudited financial results and the Limited Review Report from the Statutory Auditor. The company reported a net loss after tax for the quarter. The filing also addresses the impact of a fire incident in the previous year, ongoing operational disruptions, and the company's exploration of alternative manufacturing arrangements. The company confirmed no defaults on loans or debt securities.
Key Highlights
- Lasa Supergenerics declared unaudited financial results for Q1 FY27.
- Board approved results and Limited Review Report from auditors.
- Company reported a net loss after tax for the quarter.
- Ongoing operational disruptions due to a previous fire incident noted.
- Exploring contract manufacturing and facility leasing options.
Price Impact
More from LASA